Romania

Despite general economic instability and a rise in prices, the analgesics category in 2023 looks set to achieve a positive performance. However, the current value growth rate is likely to be slower than in the previous year. This can be attributed to…

Despite ongoing economic instability and the high rate of inflation, the consumer health market in Romania is witnessing steady growth in 2023. Notably, it is the categories of vitamin and dietary supplements, cough, cold and allergy (hay fever)…

Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…

International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…

As a result of the COVID-19 crisis, consumers have become more informed, leading to continued benefits for dietary supplements. In 2023, combination dietary supplements dominate the market, accounting for a significant portion of overall value sales.…